The Alumkal laboratory focuses on identifying mechanisms by which prostate cancer progresses to the lethal form of the disease that is resistant to male hormone-lowering therapies. We believe molecular methods can be used to understand this process. Our goal is to apply insights from the lab to clinical trials for patients.